Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 919-274-6 | CAS number: -
Endpoint summary
Administrative data
Description of key information
The following information is available for the acute toxicity endpoints:
Rodabaugh D.D. (20008a) An acute oral toxicity study in rats with AS305BD (Acute toxic class method) OECD 423. Testing laboratory: Charles River Laboratories, Preclinical Services. Report no.: LMT00078. Owner company: Chevron. Report date: 2008-02-13.
Rodabaugh D.D. (2008b) An acute oral toxicity study of AS305BD administered by the dermal route to rats. Testing laboratory: Charles River Laboratories, Preclinical Services. Report no.: LMT00091. Owner company: Chevron. Report date: 2008-02-20.
These studies have been rated as 1 under the Klimisch scoring system and so are considered to be sufficient to address these endpoints.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
The substance is of low acute toxicity following oral and dermal exposure, with LD50 values determined to be greater than the limit dose of 2000 mg/kg bw.No data are available on acute inhalation toxicity however, this route of exposure is unlikely to occur on the basis of the vapour pressure of the substance and the unlikely possibility to generate aerosol, particles or droplets of an inhalable size.
Justification for classification or non-classification
The substance does not require any classification for acute oral and dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
